Colinz Laboratories Ltd

BSE :531210 NSE :- Sector : Pharmac..
43.70
Change: -2.30(-5.00%)
No Graph Available
52 week Low
36.00
52 week High
84.40
Day low
43.70
Day high
45.08
Prev Close
46.00
Open
45.08
6M return
-20.46%
1Y return
6.07%
MCap(Rs. in Cr.)
19.98
Total Volume
699
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
27.00
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0.24
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
5.48
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
100%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.00

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available

( in Cr.)
Year2,02,403
Pe Ratio27.00
Eps Ratio0.24
Vwap6.34
Deliverable100
Dividend Yield0
Bv Ratio5.48
FlagS
2023
2024 2025
2026


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Colinz Labs
43.70
Change: -2.30 (-5.00%)
1 Year return
6.07%
Risk (Std Dev)
0.20%
PE Ratio
41.62
MCap( in Cr.)
19.98
Shukra Pharma.
205.60
Change: 3.05 (1.51%)
1 Year return
319.08%
Risk (Std Dev)
0.48%
PE Ratio
109.95
MCap( in Cr.)
900.28
Oxygenta Pharma
82.56
Change: -1.68 (-1.99%)
1 Year return
159.46%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
305.34
Everest Organics
243.65
Change: -12.80 (-4.99%)
1 Year return
78.89%
Risk (Std Dev)
0.35%
PE Ratio
NM
MCap( in Cr.)
249.03
Pharmaids Pharma
61.94
Change: 0.00 (0.00%)
1 Year return
19.83%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
218.45
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth with a of %

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

2023
2024
2025

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

View More

News

Stay tuned to the latest developments and happenings in the company.

Colinz Laboratories standalone net profit declines 54.55% in the December 2024 quarter

Net profit of Colinz Laboratories declined 54.55% to Rs 0.05 crore in the quarter ended December 2024 as against Rs 0.11 crore during the previous qua....

01 Feb 2025 07:43

Colinz Laboratories to announce Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live News....

14 Jan 2025 12:59

Colinz Laboratories standalone net profit rises 33.33% in the September 2024 quarter

Net profit of Colinz Laboratories rose 33.33% to Rs 0.16 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarte....

31 Oct 2024 07:32

Colinz Laboratories to table results

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live News....

15 Oct 2024 10:07

Colinz Laboratories to hold AGM

Colinz Laboratories announced that the 38th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capi....

16 Aug 2024 14:50

Colinz Laboratories standalone net profit rises 16.67% in the June 2024 quarter

Net profit of Colinz Laboratories rose 16.67% to Rs 0.14 crore in the quarter ended June 2024 as against Rs 0.12 crore during the previous quarter end....

01 Aug 2024 07:25

View More
Subscribe for our
newsletter
Open Account Now